Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-01-10 @ 7:29 PM
Study NCT ID:
NCT05335993
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-10
First Post:
2022-02-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
Sponsor:
CanariaBio Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Ovarian Cancer | View |
| None | Recurrent Epithelial Cancer of Ovary | View |
| None | Recurrent Epithelial Ovarian Cancer | View |
| None | Recurrent Fallopian Tube Cancer | View |
| None | Peritoneal Cancer | View |
| None | Recurrent Carcinoma of Ovary | View |
| None | Adenocarcinoma of Ovary | View |
Keywords: